학술논문
Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy
Document Type
Article
Author
Source
In: Canadian Journal of Cardiology . (Canadian Journal of Cardiology, March 2014, 30(3):359-367)
Subject
Language
English
ISSN
0828282X